WeChat

简体中文
 

Achievements

  • [PNAS] Broad neutralizing antibody response of a monomeric spike–based SARS-CoV-2 bivalent vaccine against diverse variants

    2025-08-28
  • [The Lancet Regional Health-Western Pacific] Immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil9 in Chinese women aged 18–26 years: three-year follow-up data from a randomised clinical trial

    2025-08-27
  • [The Lancet Regional Health-Western Pacific] Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort

    2025-08-24
  • [Research] Three-Dimensional Curved Workflow-Based Optical Coherence Tomography Angiography for Enhancing Atopic Dermatitis Theranostics

    2025-08-14
  • [Journal of Hepatology] Antibodies elicited by hepatitis E vaccination in humans confer cross-genus protection against rat hepatitis E virus

    2025-06-28
  • [Science Translational Medicine] Targeted suppression of glioma by ultralow-dose X-ray-induced photodynamic therapy and gold-based nanoclusters in preclinical models

    2025-06-12
  • WHO Prequalifies China-Made HIV Urine Self-Test Kit Developed by Our School

    2025-05-14
  • [Cancer Research] SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T cell Activity in Hepatocellular Carcinoma

    2025-04-27
  • [Nature Communications] Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study

    2025-02-18
  • ​[PNAS] Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase

    2025-02-07
    • FirstPrevious1234NextLast